Route of administration other than oral for concomitant me­di­cation [Bioanalytics]

posted by qualityassurance – 2020-02-04 12:28 (1943 d 14:20 ago) – Posting: # 21141
Views: 4,827

Hello all,

We have given concomitant medication to subjects during clinical phase and the route of administration was topical, local (eye drops), IV, IM.

Can anyone suggest me :confused::confused: if it is required to include these medications in concomitant medication experiment if the route of administration is other than oral (e.g. IV, topical, eye drops) during clinical phase?

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
65 visitors (0 registered, 65 guests [including 13 identified bots]).
Forum time: 03:48 CEST (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5